For example, a study involving 47 patients with acquired demyelinating disease found serum antibodies against Kir4.1 in 57.45% patients but absent in 62 with other neurologic disease or autoimmune disease or the healthy controls [72]. This evidence concerns the gene KCNJ10 and nervous system disorder.